Attenuation of experimental autoimmune myocarditis by si-RNA mediated CD40 silencing

International Heart Journal

Volumn 55, Issue 6, 2014, Pages 539-545

  Gong, Xin ^a,b   Han, Bo ^a   Zou, Yong ^c   Wang, Jiezhong ^a   Yang, Wenwei ^a  

^a Division of Cardiology Department of Pediatrics Provincial Hospital Affiliated with handong University   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c Department of Combined Traditional Chinese and Western Medicine ^*  (China)

Author keywords

Lymphocyte; RNA interference

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; LENTIVIRUS VECTOR; MYOSIN; MYOSIN ANTIBODY; SMALL INTERFERING RNA; TH2 CYTOKINE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYOCARDITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RNA INTERFERENCE; SEQUENCE ANALYSIS; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; LEWIS RAT; METABOLISM;

ANIMALS; ANTIGENS, CD40; CYTOKINES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; IMMUNE SYSTEM; MALE; MYOCARDITIS; RATS, INBRED LEW; RNA, SMALL INTERFERING;

EID: 84924813659     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-125     Document Type: Article

References (45)

1. Liu X, Zhu X, Wang A, Fan H, Yuan H. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis. Int J Cardiol 2009; 137: 282-8.
2. Okabe TA, Hattori M, Yuan Z, Kishimoto C. L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes. Int J Exp Pathol 2008; 89: 382-8.
3. Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003; 60: 11-25. (Review)
4. Caforio AL, Mahon NJ, McKenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001; 34: 199-204. (Review)
5. Azuma RW, Suzuki J, Ogawa M, et al. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation. Cardiovasc Res 2004; 64: 412-20.
6. Makino N, Toyofuku T, Takegahara N, et al. Involvement of Sema4A in the progression of experimental autoimmune myocarditis. FEBS Lett 2008; 582: 3935-40.
7. Afanasyeva M, Wang Y, Kaya Z, et al. Interleukin-12 receptor/ STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001; 104: 3145-51.
8. Raoul C, Abbas-Terki T, Bensadoun JC, et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005; 11: 423-8.
9. Hill JA, Ichim TE, Kusznieruk KP, et al. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol 2003; 171: 691-6.
10. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007; 6: 443-53.(Review)
11. Peng X, Kasran A, Warmerdam PA, de Boer M, Ceuppens JL. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferongamma production. Eur J Immunol 1996; 26: 1621-7.
12. Mackey MF, Gunn JR, Maliszewsky C, Kikutani H, Noelle RJ, Barth RJ Jr. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 1998; 161: 2094-8.
13. O’Garra A, Hosken N, Macatonia S, Wenner CA, Murphy K. The role of macrophage-and dendritic cell-derived IL12 in Th1 phenotype development. Res Immunol 1995; 146: 466-72. (Review)
14. Sun W, Wang Q, Zhang L, et al. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin. Transplantation 2003; 76: 1351-9.
15. Liu L, Rich BE, Inobe J, Chen W, Weiner HL. Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol 1998; 10: 1017-26.
16. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002; 80: 477-83. (Review)
17. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70: 83-243. (Review)
18. Matsui Y, Inobe M, Okamoto H, et al. Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis. J Mol Cell Cardiol 2002; 34: 279-95.
19. Tang A, Judge TA, Nickoloff BJ, Turka LA. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J Immunol 1996; 157: 117-25.
20. Brown DL, Bishop DK, Wood SY, Cederna PS. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function. Plast Reconstr Surg 2006; 117: 2250-8.
21. Pochanke V, Hatak S, Hengartner H, Zinkernagel RM, McCoy KD. Induction of IgE and allergic-type responses in fur mite-infested mice. Eur J Immunol 2006; 36: 2434-45.
22. Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002; 99: 4601-9.
23. Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med 2007; 39: 440-56. (Review)
24. Haga T, Suzuki J, Kosuge H, et al. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. J Mol Cell Cardiol 2009; 46: 719-27.
25. Ohshima M, Yamahara K, Ishikane S, et al. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis. J Mol Cell Cardiol 2012; 53: 420-8.
26. Leon JS, Wang K, Engman DM. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 2003; 107: 2264-9.
27. Suzuki M, Zheng X, Zhang X, et al. Inhibition of allergic responses by CD40 gene silencing. Allergy 2009; 64: 387-97.
28. Takeuchi A, Mishina Y, Miyaishi O, Kojima E, Hasegawa T, Isobe K. Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis. Nat Genet 2003; 33: 172-6.
29. Feuerer M, Eulenburg K, Loddenkemper C, Hamann A, Huehn J. Self-limitation of Th1-mediated inflammation by IFN-gamma. J Immunol 2006; 176: 2857-63.
30. Valaperti A, Marty RR, Kania G, et al. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008; 180: 2686-95.
31. Rangachari M, Mauermann N, Marty RR, et al. T-bet negatively regulates autoimmune myocarditis by suppressing local produc tion of interleukin 17. J Exp Med 2006; 203: 2009-19.
32. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876-90. (Review)
33. Fabre A, Sheppard MN. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 2006; 92: 316-20.
34. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.
35. Heart Failure Society Of America. Myocarditis: Current treatment. J Card Fail 2006; 12: e120-2. (Review)
36. Ye F, Shi B, Wu X, et al. Experience with lentivirus-mediated CD40 gene silencing in a mouse model of Graves’ disease. J Endocrinol 2011; 208: 285-91.
37. Law CL, Grewal IS. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv Exp Med Biol 2009; 647: 8-36. (Review)
38. Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37: 457-64. (Review)
39. Zheng X, Vladau C, Zhang X, et al. A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood 2009; 113: 2646-54.
40. Suzuki M, Zheng X, Zhang X, et al. Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol 2008; 180: 8461-9.
41. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-3.
42. Liu W, Li WM, Gao C, Sun NL. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. J Autoimmun 2005; 25: 258-63.
43. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14. (Review)
44. Allenbach Y, Solly S, Grégoire S, et al. Role of regulatory T cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 2009; 174: 989-98.
45. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A 2008; 105: 10113-8.